THERIOS 300MG PALATABLE TABLETS FOR DOGS
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
11-05-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CEFALEXIN
Available from:
Sogeval
ATC code:
QJ01DB01
Dosage:
300 Milligram
Pharmaceutical form:
Tablets
Therapeutic group:
Antibacterial
Therapeutic area:
Canine
Authorization date:
2010-04-16
Summary of Product characteristics
IRISH MEDICINES BOARD ACT 1995, AS AMENDED
EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007
VPA: 10814/005/002
Case No: 7008096
The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby
grants to:
SOGEVAL
200 AVENUE DE MAYENNE, BP 2227, 53002 LAVAL CEDEX 9, FRANCE
an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the
Veterinary Medicinal Product:
THERIOS 300MG PALATABLE TABLETS FOR DOGS
The particulars of which are set out in the attached Schedule. The authorisation is also subject to any special conditions as may be specified in
the Schedule.
The authorisation,unless revoked, shall continue in force from 05/08/2010 until 15/04/2015.
Signed on behalf of the Irish Medicines Board
________________
A person authorised in that behalf by the said Board.
(NOTE: This authorisation replaces any previous authorisation in respect of this product which is now null and void.)
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 07/08/2010_
_CRN 7008096_
_page number: 1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Therios 300 mg palatable tablets for dogs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Tablet.
Round scored beige palatable tablet.
The tablet can be divided into equal halves and quarters.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of bacterial skin infections in dogs (including deep and superficial pyoderma) caused by organisms
sensitive to cefalexin.
For the treatment of urinary tr
Read the complete document
